Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are…
Saved company profile
Historical company information from a saved The Jobs API profile (LinkedIn/Crunchbase fields). It is not live-verified; figures may have changed. Missing values remain unknown.
Transformative Targeted Therapies
Full company description
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
LinkedIn followers
10,215
People associated on LinkedIn
181
Reported office locations
18702 North Creek Pkwy, 100, Bothell, Washington 98011, US
Business categories
Biopharma
Biotechnology
Medical
Pharmaceutical
Other recorded names
Immunome, Inc.
Specialties
Biotechnology
Profile identifies a recruitment agency
No
Reported total investment
998,854,487
Currency and observation date were not supplied; this is not a current valuation or a funding round.
Industry
Biotechnology Research
Size
51-200 employees
Headquarters
Bothell, Washington
Organization type
Public Company
Specialties
Biotechnology
Immunome, Inc. has 1 open jobs in Canada as of November 7, 2026.
7+ YOECandidates need a bachelor's degree and at least 7 years of pharmaceutical or biotech sales in oncology or rare disease. Oncology launch and oral oncolytic experience are highly desirable, along with a proven record of meeting sales targets, a valid driver's licence and the ability to travel.